Community counts: Evolution of a national surveillance system for bleeding disorders
Marilyn J. Manco‐Johnson(University of Colorado Anschutz Medical Campus), Althea M. Grant(Centers for Disease Control and Prevention), Michael Recht(McMaster University), Vanessa R. Byams(Centers for Disease Control and Prevention), Roshni Kulkarni(Mayo Clinic), Steven Humes(University of North Carolina at Chapel Hill), Suzanne Kapica(Haemophilia Foundation Australia), Diane Aschman(American Thrombosis and Hemostasis Network), Becky Dudley(American Thrombosis and Hemostasis Network), Brandi Dupervil(Centers for Disease Control and Prevention), Meredith Oakley(Centers for Disease Control and Prevention), Mariam Voutsis(Icahn School of Medicine at Mount Sinai)
Cited by 22
Related Papers
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|491
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014
|MMWR Surveillance Summaries|2016|465
ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p
|Journal of Biological Chemistry|1998|390
Emergency Department Visits Made by Patients with Sickle Cell Disease
|American Journal of Preventive Medicine|2010|207
Exo84p Is an Exocyst Protein Essential for Secretion
|Journal of Biological Chemistry|1999|204